Name: Integrated Protocol for Assessing Meningeal Lymphatics: Cisterna Magna Injection, Lymph Node Imaging, Meningeal Dissection, and Whole-Mount Staining (Video) | JoVE Journal
Uploaded: 2026-05-29T14:05:00.000+00:00
Duration: 7 min 59 s
Description: Learn an integrated protocol for assessing meningeal lymphatic vessels in mice using cisterna magna injection, lymph node imaging, and whole-mount staining. This method enables functional and morphological analysis of MLVs.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

This work was supported by funding from National Key R&#38;D Program of China (2023YFC2306500),&#160;National Natural Science Foundation of China (82502108) and China Postdoctoral Science Foundation (2024M760542).

The mouse procedures described in this protocol were performed in compliance with the protocol approved by the Institutional Animal Care and Use Committee (IACUC) of Shanghai University (Approval No. ECSHU 2023-099).&#160;
1. Preparation of surgical instruments and buffers
CAUTION: Operate in a chemical fume hood and wear gloves to minimize the potential risks when working with PFA, a moderately toxic and carcinogenic substance. All operations involving Isoamyl alcohol must be carried out in a chemical fume hood away from ignition sources, while wearing gloves and a mask, to reduce exposure risks.
<ol>
	<li>Prepare surgical instruments, such as one pair of straight scissors, two pairs of curved fine-tipped forceps, two pairs of blunt-tipped forceps, one pair of micro scissors, and one pair of straight micro forceps with smooth (non-serrated) tips. 
	NOTE: Wipe surgical instruments with 75% ethanol and keep them dry both before and after the experiment.</li>
	<li>Prepare buffers.
	<ol>
		<li>1x PBS.</li>
		<li>4% Paraformaldehyde Fix Solution (4% PFA).</li>
		<li>Blocking solution (1x PBS containing 3% bovine serum albumin (BSA), 0.5% Triton X-100, and 2% fetal bovine serum).</li>
		<li>Antibody dilution buffer (1x PBS containing 3% BSA and 0.5% Triton X-100).</li>
		<li>Antifade Mounting Medium. 
		&#8203;NOTE: The prepared reagent can be stored at 4 &#176;C for one month.</li>
	</ol>
	</li>
	<li>Prepare 2,2,2-Tribromoethanol anesthetic solution (Avertin, 1.25%, 50 mL)
	<ol>
		<li>Weigh 0.625 g Tribromoethanol into a 2 mL tube, add 1.25 mL Isoamyl alcohol, and dissolve thoroughly (37 &#176;C shaker).</li>
		<li>Transfer the fully dissolved Tribromoethanol-isoamyl alcohol solution to a 50 mL conical tube, add 1x PBS to bring the total volume to 50 mL, and mix thoroughly.</li>
		<li>Filter the solution through a 0.22 &#181;m filter in a biological safety cabinet.</li>
	</ol>
	</li>
	<li>Prepare Ovalbumin, Alexa Fluor 647 Conjugate (OVA-647) solution (2 mg/mL). Dissolve 2 mg of OVA-647 in 1 mL of artificial cerebrospinal fluid (aCSF).</li>
</ol>
2. Assembly of the injection needle and connection to the microinjection pump
<ol>
	<li>Use blunt forceps to break off the 30 G needle and retain the tip11 (outer diameter 0.30 mm, inner diameter 0.15 mm, length 8 mm).</li>
	<li>Use a 30 cm length of PE-10 tubing (outer diameter 0.64 mm, inner diameter 0.28 mm) to connect the broken 30 G needle to the microinjection needle containing a 30 G needle (Figure 1).</li>
	<li>Mount the microinjection needle, with the tubing and 30 G needle attached, onto the microinjection pump.</li>
</ol>
3. i.c.m. injection and live imaging
CAUTION: If the needle is inserted too deeply and penetrates the brain parenchyma, the injectate will be delivered into the brain tissue rather than the CSF compartment, compromising the accuracy of the result and potentially leading to mouse mortality. During the surgical procedure, continuous physiological monitoring of the mouse is required. Anesthesia depth should be assessed every 15 min using the toe-pinch reflex to ensure the animal remains pain-free. Body temperature should be maintained at 37 &#176;C &#177; 0.5 &#176;C using a heating pad to prevent hypothermia and its associated effects on physiological function. Additionally, respiration and heart rate should be recorded every 30 min, assessed by observing thoracic movements and palpating the cardiac apex. During i.c.m. injection, if the needle is inserted too deeply and causes bleeding, this indicates a failed injection. Terminate the experiment and euthanize the animal.
<ol>
	<li>Weigh the mouse and administer 200 mg/kg Avertin via intraperitoneal injection to anesthetize the mouse. 
	NOTE: Alternative anesthetics (e.g., ketamine/xylazine) can be used.</li>
	<li>Apply ophthalmic ointment to prevent corneal drying.</li>
	<li>Apply depilatory cream to the cervical region to remove hair over the lymph nodes when the toe pinch reflex ceases, and respiration becomes slow and steady.</li>
	<li>Shave the dorsal neck region.</li>
	<li>Place the mouse in a stereotaxic frame on a heating pad with the head tilted at a 120&#176; angle to the trunk (Figure 2A).</li>
	<li>Clean the area sequentially with povidone-iodine and 75% ethanol.</li>
	<li>Make a midline incision in the skin of the neck and bluntly separate the muscle layers. 
	NOTE: Using two pairs of blunt-tipped forceps, separate the muscle layers to minimize bleeding.</li>
	<li>Dissect through the muscle with fine-tipped forceps until the translucent dura mater overlying the CM becomes visible&#160;(Figure 2B, C). 
	NOTE: Use a fine-tipped curved forceps to retract the muscles and maintain consistent exposure of the CM.</li>
	<li>Under a stereomicroscope, use blunt forceps to hold the needle and insert it at a 45&#176; angle to the plane of the dura mater to a depth of approximately 1&#8211;2 mm. Position the needle bevel parallel to the dura mater so that it lies completely beneath the dura mater (Figure 2D). 
	NOTE: Apply gentle force with the needle to puncture the dura mater. Successful puncture is indicated by a palpable loss of resistance, along with visualization of the needle tip beneath the dura mater and the outflow of CSF.</li>
	<li>Use absorbent paper to dry any leaking CSF.</li>
	<li>Set the microinjection pump to deliver at 1 &#181;L/min. Inject 5 &#181;L of OVA-647 solution (2 mg/mL) into the CM4 (Figure 2E).</li>
	<li>Leave the needle in place for 2 min to prevent backflow.</li>
	<li>Apply one drop of biological glue onto the meninges.</li>
	<li>Close the surgical incision.</li>
	<li>While still under anesthesia, perform in vivo imaging of the mouse to monitor dye intensity in the CLNs at various time points (30 min, 60 min). Use the following imaging parameters: exposure time: 0.5 s; excitation filter: 640 nm; emission filter: 680 nm. Continue to monitor anesthetic depth and supplement with additional anesthetics if needed.</li>
</ol>
4. Isolating the dorsal aspect of the mouse skull
NOTE: Confirm the absence of the toe pinch reflex and the cessation of spontaneous respiration before initiating thoracic dissection.
<ol>
	<li>Euthanize the mouse with an overdose of Avertin (600 mg/kg) and perform cardiac perfusion with 20 mL 1x PBS or normal saline.</li>
	<li>Decapitate the mouse to isolate the head.</li>
	<li>Make an incision along the midline of the skull to open the scalp.</li>
	<li>Use two curved hemostats to separate the scalp bilaterally by gentle retraction. Subsequently, insert the curved hemostats into the orbital fossae and carefully strip off the residual scalp from the nasal and oral regions (Figure 3A&#8211;C). 
	NOTE: This method enables rapid and complete separation of the scalp.</li>
	<li>Remove the mandible while keeping the skull intact (Figure 3D).</li>
	<li>Remove the bone from the base of the skull to expose the ventral aspect of the brain (Figure 3E).</li>
	<li>Carefully extract the brain with blunt forceps, avoiding contact with the dura mater of the parietal bones (Figure 3F).</li>
	<li>Completely immerse the dorsal skull in 5 mL, 4% PFA and fix for 24 h at 4 &#176;C (Figure 3G). 
	PAUSE POINTS: Store fixed skulls at 4 &#176;C for no longer than one week. Remove the sample from 4 &#176;C and allow it to return to room temperature before meningeal dissection.</li>
</ol>
5. Dissection of meninges from the mouse skull
<ol>
	<li>Wash the fixed skull with 5 mL 1x PBS, repeating the wash three times (10 min each).</li>
	<li>Place the skull dorsal-side down in a 10-cm dish filled with 1x PBS&#160;(Figure 4A).</li>
	<li>Use the tip of fine-tipped forceps to grasp or press down on the tympanic bulla and remove it from the skull (Figure 4B). 
	NOTE: Removing the tympanic bulla is a critical step to avoid meningeal tearing caused by adhesion during separation from the skull.</li>
	<li>Trim closely along the ventral surface of the skull for a distance of about 2 mm with scissors to smooth them (Figure 4C).</li>
	<li>Use fine forceps, meticulously clear residual white tissue from the confluence of sinuses (COS) region of the meninges&#160;(Figure 4D). 
	NOTE: Incomplete removal of residual tissue is a major cause of nonspecific staining in immunolabeling.</li>
	<li>Use fine micro forceps to gently lift one edge of the meninges from the skull margin, then lift the opposite edge (Figure 4E, F).</li>
	<li>Grasp the bowl-shaped rim of the meninges and pull to separate it from the skull in the COS region (Figure 4G).</li>
	<li>Remove the maxillary bone with scissors (Figure 4H).</li>
	<li>Grasp the bowl-shaped rim of the meninges again and pull to separate the meninges from the skull at the frontal bone area (Figure 4I).</li>
	<li>Place the intact meninges into a 24-well plate containing 1 mL 1x PBS, ready for staining. 
	NOTE: If the meninges rupture during the autopsy, especially at the junction of the superior sagittal and transverse sinuses, the sample may not be suitable for further analysis. If high non-specific background staining is observed, add a quenching step after PFA fixation (e.g., incubate with 0.1 M glycine solution for 40 min12) to further reduce the background signal.</li>
</ol>
6. Blocking, primary antibody, and secondary antibody staining
<ol>
	<li>Use a 1 mL pipette to aspirate the 1x PBS so that the meninges adhere to the bottom of the well plate.</li>
	<li>Block the whole-mount meninges with 200 &#181;L blocking solution in a 24-well plate for 1 h at room temperature. 
	NOTE: Gently spread the meninges completely in the blocking solution using forceps to ensure even exposure.</li>
	<li>Use a pipette to remove the blocking solution.</li>
	<li>Incubate the whole-mount meninges with 200 &#181;L of diluted anti-LYVE-1 (lymphatic vessel-specific marker13) antibody at a 1:200 dilution (final concentration 1 &#181;g/mL) overnight at 4 &#176;C.</li>
	<li>Use a pipette to remove the antibody solution.</li>
	<li>Wash three times with 1x PBS (10 min each).</li>
	<li>Incubate whole-mount meninges with the DAPI (final concentration 1 &#181;g/mL) and Alexa Fluor 488 donkey anti-rat IgG (final concentration 2 &#181;g/mL) for 1 h at room temperature in 1x PBS. 
	NOTE: Protect from light during antibody incubation.</li>
	<li>Use a pipette to remove the antibody solution.</li>
	<li>Wash three times with 1x PBS (10 min each).</li>
</ol>
7. Mounting and imaging
<ol>
	<li>Pipette 100 &#181;L of 1x PBS onto the center of a slide.</li>
	<li>Float and spread the whole-mount meninges within the droplet (Figure 5A).</li>
	<li>Aspirate the 1x PBS to allow the tissue to adhere flatly to the slide (Figure 5B).</li>
	<li>Apply 20 &#181;L of mounting medium onto the whole-mount meninges.</li>
	<li>Place a coverslip over the tissue (Figure 5C).</li>
	<li>Air-dry the slides at room temperature and store the slides at 4 &#176;C. 
	PAUSE POINTS: The slides can be stored at 4 &#176;C for up to one month. Remove the slide from 4 &#176;C and allow it to return to room temperature. Remove any condensation from the slide surface with absorbent paper.</li>
	<li>Use a 20x objective lens to acquire MLVs images. Set the channel to FL Green with an emission wavelength of 518 nm and an exposure time of 100 ms.</li>
</ol>

<ol>
	<li>Louveau, A., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Structural+and+functional+features+of+central+nervous+system+lymphatic+vessels.">Structural and functional features of central nervous system lymphatic vessels.</a> Nature. 523, 337-341 (2015).</li><li>Aspelund, A., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+dural+lymphatic+vascular+system+that+drains+brain+interstitial+fluid+and+macromolecules.">A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules.</a> J Exp Med. 212, 991-999 (2015).</li><li>Sandrone, S., Moreno-Zambrano, D., Kipnis, J., Van Gijn, J. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=A+(delayed)+history+of+the+brain+lymphatic+system.">A (delayed) history of the brain lymphatic system.</a> Nat Med. 25, 538-540 (2019).</li><li>Da Mesquita, S., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Functional+aspects+of+meningeal+lymphatics+in+ageing+and+alzheimer's+disease.">Functional aspects of meningeal lymphatics in ageing and alzheimer's disease.</a> Nature. 560, 185-191 (2018).</li><li>Hu, X., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Meningeal+lymphatic+vessels+regulate+brain+tumor+drainage+and+immunity.">Meningeal lymphatic vessels regulate brain tumor drainage and immunity.</a> Cell Res. 30, 229-243 (2020).</li><li>Li, X., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Meningeal+lymphatic+vessels+mediate+neurotropic+viral+drainage+from+the+central+nervous+system.">Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system.</a> Nat Neurosci. 25, 577-587 (2022).</li><li>Rustenhoven, J., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Age-related+alterations+in+meningeal+immunity+drive+impaired+cns+lymphatic+drainage.">Age-related alterations in meningeal immunity drive impaired cns lymphatic drainage.</a> J Exp Med. 220, (2023).</li><li>Kodama, T., Hatakeyama, Y., Kato, S., Mori, S. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Visualization+of+fluid+drainage+pathways+in+lymphatic+vessels+and+lymph+nodes+using+a+mouse+model+to+test+a+lymphatic+drug+delivery+system.">Visualization of fluid drainage pathways in lymphatic vessels and lymph nodes using a mouse model to test a lymphatic drug delivery system.</a> Biomed Opt Express. 6, 124-134 (2015).</li><li>Banerjee, R., Knauer, L. A., Yang, Y. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Protocol+for+in+vivo+and+in+vitro+study+of+lymphatic+valve+formation+driven+by+shear+stress+signaling+pathway.">Protocol for in vivo and in vitro study of lymphatic valve formation driven by shear stress signaling pathway.</a> STAR Protoc. 4, 102141 (2023).</li><li>Akwii, R. G., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Murine+dermal+lymphatic+endothelial+cell+isolation.">Murine dermal lymphatic endothelial cell isolation.</a> J Vis Exp. (197), e65393 (2023).</li><li>Xavier, A. L. R., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Cannula+implantation+into+the+cisterna+magna+of+rodents.">Cannula implantation into the cisterna magna of rodents.</a> J Vis Exp. (135), e57378 (2018).</li><li>Hsieh, Y. T., Chen, S. L. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Visualization+and+analysis+of+neuromuscular+junctions+using+immunofluorescence.">Visualization and analysis of neuromuscular junctions using immunofluorescence.</a> Bio Protoc. 14, e5076 (2024).</li><li>Banerji, S., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Lyve-1,+a+new+homologue+of+the+cd44+glycoprotein,+is+a+lymph-specific+receptor+for+hyaluronan.">Lyve-1, a new homologue of the cd44 glycoprotein, is a lymph-specific receptor for hyaluronan.</a> J Cell Biol. 144, 789-801 (1999).</li><li>Da Mesquita, S., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Meningeal+lymphatics+affect+microglia+responses+and+anti-abeta+immunotherapy.">Meningeal lymphatics affect microglia responses and anti-abeta immunotherapy.</a> Nature. 593, 255-260 (2021).</li><li>Betsholtz, C., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Advances+and+controversies+in+meningeal+biology.">Advances and controversies in meningeal biology.</a> Nat Neurosci. 27, 2056-2072 (2024).</li><li>Ma, Q., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Rapid+lymphatic+efflux+limits+cerebrospinal+fluid+flow+to+the+brain.">Rapid lymphatic efflux limits cerebrospinal fluid flow to the brain.</a> Acta Neuropathol. 137, 151-165 (2019).</li><li>Hablitz, L. M., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=Increased+glymphatic+influx+is+correlated+with+high+eeg+delta+power+and+low+heart+rate+in+mice+under+anesthesia.">Increased glymphatic influx is correlated with high eeg delta power and low heart rate in mice under anesthesia.</a> Sci Adv. 5, eaav5447 (2019).</li><li>Lee, H., et al. <a target="_blank" href="https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed&cmd=Search&doptcmdl=Citation&defaultField=Title+Word&term=The+effect+of+body+posture+on+brain+glymphatic+transport.">The effect of body posture on brain glymphatic transport.</a> J Neurosci. 35, 11034-11044 (2015).</li></ol>

The authors declare no competing interests.

This protocol provides a comprehensive method for evaluating MLVs function and morphology by integrating i.c.m. injection, in vivo imaging of CLNs, meningeal dissection, and whole-mount staining. A key advantage of this integrated approach over conventional methods is that it enables simultaneous assessment of lymphatic drainage function and vessel morphology within the same animal, eliminating the need for separate cohorts and thereby reducing experimental variability while improving data comparability. Further...

MLVs are located within the dural sinuses and are able to carry CSF components and immune cells from the CNS to the CLNs1,2. The discovery of MLVs has challenged the traditional concept of central nervous system &#34;immune privilege&#34; and has emerged as a research hotspot in recent years3. Studies have shown that impaired MLVs function is closely associated with various diseases, including Alzheimer&#39;s disease, age-related cognitive decline, brain tumors, and CNS infections4,5,6,7. As research in this field advances, there is a growing need for integrated, reproducible, and well-standardized experimental methods.
Most existing protocols for lymphatic vessel research focus on peripheral lymphatic vessels8,9,10. In studies related to MLVs,&#160;A study described a straightforward CM cannulation procedure that enables direct access to the CSF without damaging the skull or brain parenchyma11. When combined with imaging techniques, this method can effectively assess glymphatic system function and CSF dynamics. However, detailed experimental protocols for studying the function and morphology of MLVs have not been well documented.
The present protocol integrates functional imaging with morphological analysis, enabling simultaneous acquisition of drainage function and structural morphology data from the same animal, thereby reducing the number of animals used and improving data comparability and consistency. Overall, this protocol can be used to study structural and functional changes in MLVs in various disease models, as well as to evaluate the effects of pharmacological or genetic interventions on MLVs. The protocol provides detailed descriptions of the operational steps, key precautions, and troubleshooting guidance. In addition, the i.c.m. injection technique described in this protocol can be independently applied for intracranial drug delivery, and the meningeal dissection procedure is compatible with fresh tissue for subsequent RNA or protein extraction, offering considerable flexibility and scalability.

<table><tbody><tr><td>ACSF (Artificial Cerebrospinal Fluid)</td><td>Tocris&amp;nbsp;&amp;nbsp;</td><td>Cat# 3525</td><td></td></tr><tr><td>Alexa Fluor 488 donkey anti-rat IgG (1:1000 dilution)</td><td>Invitrogen</td><td>Cat# A-21208</td><td></td></tr><tr><td>Antifade Mounting Medium</td><td>Beyotime</td><td>Cat# P0126</td><td></td></tr><tr><td>Blunt-tipped forceps</td><td>RWD Life Science</td><td>Cat# F12011-10</td><td></td></tr><tr><td>BSA</td><td>Beyotime</td><td>Cat# ST023</td><td></td></tr><tr><td>Coverslips</td><td>CITOTEST</td><td>Cat# 80312-3161</td><td></td></tr><tr><td>Curved sharp forceps</td><td>RWD Life Science</td><td>Cat# F11003-11</td><td></td></tr><tr><td>DAPI</td><td>Sigma-Aldrich</td><td>Cat# D9542</td><td></td></tr><tr><td>Depilatory cream</td><td>Veet</td><td>N/A</td><td></td></tr><tr><td>Dish-10 cm</td><td>Thermo Fisher Scientific</td><td>Cat# 150464</td><td></td></tr><tr><td>Disposable intravenous (IV) infusion needle</td><td>Zhejiang Kindly Medical Devices&amp;nbsp;</td><td>N/A</td><td></td></tr><tr><td>Ethanol-75%</td><td>Sinopharm Chemical Reagent&amp;nbsp;</td><td>Cat# 80176961</td><td></td></tr><tr><td>Fetal Bovine Serum</td><td>Excell</td><td>Cat# FSD500</td><td></td></tr><tr><td>Filter-0.22 &amp;micro;m</td><td>Merck Millipore&amp;nbsp;</td><td>Cat# SLGPR33RB</td><td></td></tr><tr><td>Glass slides</td><td>CITOTEST</td><td>Cat# 80340-3610</td><td></td></tr><tr><td>Isoamyl alcohol</td><td>Sinopharm Chemical Reagent&amp;nbsp;</td><td>Cat# 10003218</td><td></td></tr><tr><td>IVIS Spectrum</td><td>PerkinElmer</td><td>N/A</td><td></td></tr><tr><td>Micro forceps</td><td>Shinva Medical Instrument&amp;nbsp;</td><td>Cat# ZD372RB&amp;nbsp;</td><td></td></tr><tr><td>Micro scissors</td><td>Shinva Medical Instrument&amp;nbsp;</td><td>Cat# ZO13056R</td><td></td></tr><tr><td>Microinjection needle (25 &amp;micro;L)</td><td>Shanghai Gaoge Industry &amp;amp; Trade&amp;nbsp;</td><td>N/A</td><td></td></tr><tr><td>Microinjection pump</td><td>Voyage Power</td><td>Cat# QHZS-001A</td><td></td></tr><tr><td>Mouse: C57BL/6 wild-type, 8 weeks old, male&amp;nbsp;</td><td>Cavens</td><td>N/A</td><td></td></tr><tr><td>Needle-30G</td><td>Zhejiang Kindly Medical Devices&amp;nbsp;</td><td>N/A</td><td></td></tr><tr><td>Normal Saline</td><td>Beyotime</td><td>Cat# ST341</td><td></td></tr><tr><td>Ovalbumin, Alexa Fluor&amp;trade; 647 Conjugate</td><td>Thermo Fisher Scientific</td><td>Cat# O34784</td><td></td></tr><tr><td>Paraformaldehyde Fix Solution-4%</td><td>Beyotime</td><td>Cat# P0099</td><td></td></tr><tr><td>PE-10 tubing</td><td>Shanghai Qiujing Biochemical Reagent and Instrument</td><td>N/A</td><td></td></tr><tr><td>Phosphate-buffered saline (1x PBS)</td><td>Beyotime</td><td>Cat# ST447</td><td></td></tr><tr><td>Rat anti-LYVE-1 (1:200 dilution)</td><td>Santa Cruz</td><td>Cat# sc-65647</td><td></td></tr><tr><td>Stereomicroscope</td><td>Jonec</td><td>Cat# JSZ6</td><td></td></tr><tr><td>Stereotaxic frame</td><td>RWD Life Science</td><td>Cat# 68030</td><td></td></tr><tr><td>Straight scissors</td><td>RWD Life Science</td><td>Cat# S12007-10</td><td></td></tr><tr><td>Syringe-1-mL&amp;nbsp;</td><td>Zhejiang Kindly Medical Devices&amp;nbsp;</td><td>N/A</td><td></td></tr><tr><td>Tissue Adhesive I</td><td>3M Vetbond</td><td>Cat# 1469SB</td><td></td></tr><tr><td>Tribromoethanol</td><td>Sigma-Aldrich</td><td>Cat# T48402</td><td></td></tr><tr><td>Triton X-100&amp;nbsp;</td><td>Sigma-Aldrich&amp;nbsp;</td><td>Cat# T8787</td><td></td></tr><tr><td>VS120 High-throughput fluorescence imaging system</td><td>Olympus</td><td>N/A</td><td></td></tr></tbody></table>

integrated protocol for assessing meningeal lymphatics: cisterna magna injection, lymph node imaging, meningeal dissection, and whole-mount staining

Integrated Protocol for Assessing Meningeal Lymphatics: Cisterna Magna Injection, Lymph Node Imaging, Meningeal Dissection, and Whole-Mount Staining

Meningeal lymphatic vessels (MLVs) have emerged as critical regulators of central nervous system (CNS) homeostasis, and MLVs dysfunction has been implicated in various neurological disorders. A comprehensive assessment of MLVs&#39; morphology and function is therefore essential for understanding their role in CNS physiology and disease. This protocol describes an integrated method for evaluating MLVs in mice using four key techniques: Intra-cisterna-magna (i.c.m.) injection of fluorescent tracers, live imaging of cervical lymph nodes (CLNs), meningeal dissection, and whole-mount staining. First, the 30 G needle is connected to the syringe and infusion pump via a polyethylene (PE) tube. After the mouse is anesthetized, the dura mater is exposed by blunt dissection of the neck muscles, and the injection needle is inserted into the cisterna magna (CM) to deliver the tracer into the cerebrospinal fluid (CSF) with precise control. Tracer drainage to the CLNs can be visualized in real time, while subsequent meningeal dissection and whole-mount staining enable detailed morphological analysis of the dorsal MLVs. The entire procedure can be completed within 3 h, encompassing i.c.m. injection, tissue perfusion, skull isolation, and placement in fixative solution. This protocol can also be adapted for intracranial drug delivery or combined with molecular analyses, as the meningeal dissection procedure is compatible with fresh, unfixed tissues suitable for RNA and protein extraction.

Following i.c.m. injection of OVA-647, in vivo imaging of small animals revealed distinct oval-shaped fluorescent signals distributed bilaterally in the cervical region (Figure 6A). In successful injections, the tracer was clearly visible in the CLNs after injection, with fluorescence intensity peaking at approximately 60 min (Figure 6B). In addition, fluorescent signals were observed in the isolated superficial and deep cervical lymph nodes (<strong cl...

Here, a protocol is presented to assess mouse meningeal lymphatic vessels (MLVs), which play an important role in multiple neurologic diseases. The goal of this protocol is to provide an integrated method that enables both functional evaluation of tracer drainage and detailed morphological characterization of the dorsal MLVs network.

Meningeal lymphatic vessels (MLVs) have emerged as critical regulators of central nervous system (CNS) homeostasis, and MLVs dysfunction has been ...

Our research focuses on mouse meninging lymphatic vessel function and morphology assessments method. This protocol supports neurological disease models, drug delivery, molecular correlation, and the translational studies. To begin, gather the surgical instruments and required buffers.Use blunt forceps to break off the 30 gauge needle and retain the tip. Using a 30 centimeter length of polyethylene 10 or PE10 tube, connect the broken 30 gauge needle to the microinjection needle containing a 30 gauge needle. Mount the assembled needle and tubing onto the microinjection pump.Weigh the mouse. After anesthetizing the mouse via intraperitoneal injection, confirm that the toe pinch reflex ceases and respiration becomes slow and steady. Apply dipilatory cream to the cervical region to remove hair over the lymph nodes.Shave the dorsal neck skin. Place the mouse in a stereotaxic frame on a heating pad. Tilt the head at a 120 degree angle to the trunk.Clean the area sequentially with povidone iodine and 75%ethanol. Make a midline incision in the skin of the neck. Using two pairs of blunt tipped forceps, separate the muscle layers.Using fine tipped forceps, dissect through the muscle until the translucent duramater overlying the cisterna magna or CM becomes visible. Retract the muscles to maintain consistent exposure. Under a stereo microscope, use blunt forceps to hold the needle.Insert the needle at a 45 degree angle to the plane of the duramater to a depth of approximately one to two millimeters. Position the needle bevel parallel to the duramater so that it lies completely beneath it. Use absorbent paper to dry any leaking cerebral spinal fluid or CSF.Set the microinjection pump to deliver at one microliter per minute. Inject five microliters of ovalbumin, AlexaFluor 647 conjugate solution into the CM, and leave the needle in place for two minutes to prevent backflow. Apply one drop of biological glue onto the meninges and close the surgical incision.Perform in vivo imaging of the mouse to monitor dye intensity in the cervical lymph nodes or CLN at 30 minutes and 60 minutes. In the IVIS acquisition control panel, select imaging wizard and click next in the pop-up window. Select spectral unmixing/filter scan and click next.Right click on the probe's name, choose dyes, select AlexaFluor 647, and click next. Select manual settings. Set the exposure time to 0.5 seconds.And use the mode with an excitation filter at 640 nanometers and an emission filter at 680 nanometers. After decapitating the euthanized mouse, make an incision along the midline of the skull to open the scalp. Using two curved hemostats, separate the scalp bilaterally by gentle retraction.Insert the curved hemostats into the orbital fossi and strip off the residual scalp from the nasal and oral regions. Remove the mandible while keeping the skull intact. Remove the bone from the base of the skull to expose the ventral aspect of the brain.Using blunt forceps, carefully extract the brain while avoiding contact with the duramater of the parietal bones. Completely immerse the dorsal skull in five milliliters of 4%paraformaldehyde. Place the sample at four degrees Celsius for 24 hours.Once the fixed skull reaches the room temperature, wash it with five milliliters of 1XPBS and repeat the wash three times for 10 minutes each. Place the skull dorsal side down in a 10 centimeter dish filled with 1XPBS. Using fine-tipped forceps, grasp or press down on the tympanic bulla, and remove it from the skull.Employing scissors, trim along the ventral surface of the skull for about two millimeters to smooth it. With forceps, clear residual white tissue from the confluence of sinuses or COS region of the meninges. Using fine micro forceps, gently lift one edge of the meninges from the skull margin.Lift the opposite edge. Grasp the bowl-shaped rim of the meninges and pull to separate it from the skull in the COS region. Remove the maxillary bone with scissors.Grasp the rim of the meninges again and pull to separate it from the skull at the frontal bone area. Place the intact meninges into a 24 well plate containing one milliliter of 1XPBS. After blocking and staining the meninges with primary and secondary antibodies, perform imaging.In vivo imaging revealed distinct oval-shaped fluorescent signals distributed bilaterally in the cervical region following injection. The tracer was clearly visible in the CLNs after injection, with fluorescence intensity peaking at approximately 60 minutes. Fluorescent signals were observed in the isolated superficial and deep cervical lymph nodes.Failed injections resulted in no detectable fluorescent signal in the cervical region. Immunofluorescent staining for lymphatic vessel endothelial hyaluronin receptor one, or LYVE1, clearly delineated the morphology of lymphatic vessels. A discontinuous LYVE1 signal due to meningeal tearing was observed, compromising reliable quantification.The absence of the transverse sinus region was visible in compromised samples. Using this approach, researchers can investigate transient function and the dorsal ML-based nasal work morphology in mice. The biggest challenge is performing a current intrasense tendinal injections and the careful meningen dissection while preserving vessel integrity.Following this procedure, researchers can perform RNA and the protein extraction. Intracranial drug delivery or analysis in disease models.

integrated-protocol-for-assessing-meningeal-lymphatics-cisterna-magna

Research

JoVE Journal

Biology

Here we describe a protocol to perform cisterna magna cannulation (CMc), a minimally invasive way to deliver tracers, substrates and signaling molecules into the cerebrospinal fluid (CSF). Combined with different imaging modalities, CMc enables glymphatic system and CSF dynamics assessment, as well as brain-wide delivery of various compounds.

Cannula Implantation into the Cisterna Magna of Rodents

This protocol describes a technique to image different cell populations in draining lymph nodes without alterations in the organ structure.

Visualizing Lymph Node Structure and Cellular Localization using Ex-Vivo Confocal Microscopy

We describe an intracisternal injection that employs a needle bent at the tip that can be stabilized to the skull, thus eliminating the risk of damage to the underlying parenchyma. The approach can be used for genetic fate mapping and manipulations of leptomeningeal cells and for tracking cerebrospinal fluid movement.

Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

A protocol is presented combining tissue clearing with light sheet fluorescence microscopy (LSFM) to obtain three-dimensional and cellular resolution images of the lymphatic vessels and lymph nodes (LNs) collecting the cerebrospinal fluid (CSF) and spinal epidural fluid.

Three-Dimensional Imaging of the Vertebral Lymphatic Vasculature and Drainage using iDISCO+ and Light Sheet Fluorescence Microscopy

This paper presents two optimized protocols for examining resident and peripherally derived immune cells within the central nervous system, including the brain, spinal cord, and meninges. Each of these protocols helps to ascertain the function and composition of the cells occupying these compartments under steady state and inflammatory conditions.

Isolating Central Nervous System Tissues and Associated Meninges for the Downstream Analysis of Immune cells

To study cerebral blood flow regulation in vivo, traditional pharmacological methods are invasive, often damaging the skull, dura, and leptomeninges. In this work, we developed a minimally invasive technique that combines nanoinjector-guided intracisternal magna (ICM) injection with laser speckle contrast imaging, preserving the integrity of the skull and leptomeninges.

Paired Cisterna Magna Nanoinjection and Laser Speckle Contrast Imaging Assay to Study Cerebral Blood Flow Regulation In Vivo

The protocol describes a method for injecting tumor cells through the percutaneous puncture route into cisterna magna that robustly induces leptomeningeal metastasis in mice, reducing trauma and extracranial tumor burden.

Minimally Invasive Cisterna Magna Injection Model for Leptomeningeal Metastasis Studies in Mice

Here, we present a protocol to clearly define the steps for anastomosing either the deep cervical lymph node or its afferent lymphatic vessel with the posterior facial vein in the rat, to minimize the influence of other variables and standardize the conduct of surgery-based research.

Surgical Protocols for Deep Cervical Lymphovenous Anastomosis in a Rat Model: Lymph Node and Lymphatic Vessel Anastomoses

This experimental protocol demonstrates a deep cervical lymph duct-cannulated rat model that enables direct and quantitative assessment of lymphatic drainage from the head region. The model facilitates detailed analysis of central nervous system (CNS)-derived solutes, immune cell populations, and the distribution and clearance of CNS-targeted therapeutics.

Cervical Lymph Duct-Cannulated Rat Model for Assessing Lymphatic Transport from the Head and Brain

This protocol assesses lymphatic drainage after fracture by combining indocyanine green(ICG) near-infrared imaging with ultrasound to quantify plantar ICG clearance and popliteal lymph node enlargement in mice.

The Assessment of Lymphatic Drainage Using ICG Near-Infrared Imaging and Ultrasound After Fracture

Learn an integrated protocol for assessing meningeal lymphatic vessels in mice using cisterna magna injection, lymph node imaging, and whole-mount staining. This method enables functional and morphological analysis of MLVs.

Integrated Protocol for Assessing Meningeal Lymphatics: Cisterna Magna Injection, Lymph Node Imaging, Meningeal Dissection, and Whole-Mount Staining (Video) | JoVE Journal

Integrated Protocol for Assessing Meningeal Lymphatics: Cisterna Magna Injection, Lymph Node Imaging, Meningeal Dissection, and Whole-Mount Staining

Explore More Videos